You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravenous Infusion

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Shanghai (Neo-T, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor
  • Neo-T
  • +3 more
  • Shanghai, China
  • +1 more
Mar 23, 2023

Total Intravenous Anesthesia, Inhalational Anesthesia, Surgical Stress Response Trial in Assiut (Target Controlled Infusion,

Not yet recruiting
  • Total Intravenous Anesthesia
  • +3 more
  • Target Controlled Infusion
  • +2 more
  • Assiut, Egypt
    Assiut University
Aug 29, 2023

Brentuximab Vedotin Intravenous Infusion "Untreated

Active, not recruiting
  • Untreated CD30-Positive Hodgkin's Lymphoma
  • Brentuximab vedotin (Genetical Recombination)
  • Tokyo, Japan
    Takeda Selected Site
Mar 24, 2022

Homozygous Familial Hypercholesterolemia Trial in Xi'an (NGGT006)

Not yet recruiting
  • Homozygous Familial Hypercholesterolemia
  • NGGT006
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Nov 5, 2023

Postoperative Pneumonia, Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Edema Trial (intravenous lidocaine

Not yet recruiting
  • Postoperative Pneumonia
  • +2 more
  • intravenous lidocaine infusion
  • Saline
  • (no location specified)
Nov 13, 2023

Rheumatoid Arthritis Trial (hUC-MSC suspension, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • hUC-MSC suspension
  • Placebo
  • (no location specified)
Aug 9, 2022

Non-variceal Gastrointestinal Bleeding Trial in Cairo (PPI group, PPI plus octreotide)

Recruiting
  • Non-variceal Gastrointestinal Bleeding
  • PPI group
  • PPI plus octreotide
  • Cairo, Egypt
    NHTMRI
Sep 28, 2023

Brentuximab Vedotin in Pediatric Hodgkin Lymphoma

Not yet recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • (no location specified)
Jul 28, 2022

Electrolyte Imbalance, Volume Overload, Hyperosmolality Trial (Enteral Dose Form, Intravenous Infusion)

Not yet recruiting
  • Electrolyte Imbalance
  • +2 more
  • Enteral Dose Form
  • Intravenous Infusion
  • (no location specified)
Jan 28, 2023

Hypopituitarism Trial in Torino (Intravenous Infusion of Diclofenac Sodium, Intravenous Infusion of Placebo)

Completed
  • Hypopituitarism
  • Intravenous Infusion of Diclofenac Sodium
  • Intravenous Infusion of Placebo
  • Torino, Piemonte, Italy
    AOU Città della Salute e della Scienza
Jan 11, 2022

Healthy Trial in Saint Petersburg (BCD-264, Darzalex)

Active, not recruiting
  • Healthy
  • Saint Petersburg, Russian Federation
  • +2 more
Jul 25, 2023

Upper GI Bleeding, Proton Pump Inhibitors Trial (Vonoprazan, esomeprazole)

Not yet recruiting
  • Upper GI Bleeding
  • Proton Pump Inhibitors
  • (no location specified)
Dec 20, 2022

Healthy Trial in Hangzhou (LPM3480392, Placebo)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    The second affiliated hosipital zhejiang university school of me
May 15, 2023

Brain Infarct Trial (0.9% NaCl 2000ml, 0.9% NaCl 0ml)

Not yet recruiting
  • Brain Infarct
  • 0.9% NaCl 2000ml
  • 0.9% NaCl 0ml
  • (no location specified)
Aug 12, 2023

Idiopathic Pulmonary Fibrosis Trial (SHR-1906, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Feb 1, 2023

CNS Effects of Diphenhydramine, Pharmacokinetics of Diphenhydramine Trial in Amherst (DiphenhydrAMINE Injectable Solution)

Terminated
  • Central Nervous System Effects of Diphenhydramine
  • Pharmacokinetics of Diphenhydramine
  • DiphenhydrAMINE Injectable Solution
  • Amherst, New York
    Dent Neurologic Institute
Oct 4, 2022

Colorectal Tumors, Lidocaine Trial in Nantong (Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia,

Recruiting
  • Colorectal Tumors
  • Lidocaine
  • Administer 1.5 mg/kg intravenously to the patient before induction of anesthesia, and continue to infuse 1.5 mg/kg/h during the operation until the end of the operation
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Jul 31, 2022

Liver Cancer Trial in Chengdu (Lidocaine Hydrochloride, Injectable)

Recruiting
  • Liver Cancer
  • Lidocaine Hydrochloride, Injectable
  • Chengdu, Sichuan, China
    West China Hospital
May 10, 2022

Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance Study -

Not yet recruiting
  • Biliary Tract Cancer
    • (no location specified)
    Apr 26, 2023

    Healthy Trial in Antwerpen (BI 655088, Placebo)

    Completed
    Has Results
    • Healthy
    • BI 655088
    • Placebo
    • Edegem, Belgium
      SGS Life Science Services - Clinical Research
    Apr 20, 2022

    Healthy Volunteers Trial in Hong Kong (Ketorolac Tromethamine)

    Recruiting
    • Healthy Volunteers
    • Ketorolac Tromethamine
    • Hong Kong, Hong Kong, China
      HUK Phase 1 clinical trials center
    Jun 21, 2022

    Pancreatectomy; Hyperglycemia Trial in Hellerup (Intravenous infusion)

    Not yet recruiting
    • Pancreatectomy; Hyperglycemia
    • Intravenous infusion
    • Hellerup, Denmark
      Clinical Metabolic Physiology
    Dec 14, 2021

    Septic Shock, Critical Illness Trial in Damanhur Shubra (Heparin Infusion, subcutaneous heparin)

    Completed
    • Septic Shock
    • Critical Illness
    • Heparin Infusion
    • subcutaneous heparin
    • Damanhūr Shubrā, Egypt
      amira Bisher kassem
    Dec 18, 2022

    Skeletal Muscle Relaxation Trial (HRS3797)

    Not yet recruiting
    • Skeletal Muscle Relaxation
    • (no location specified)
    Jan 18, 2023

    POI Trial (YB-1113)

    Not yet recruiting
    • POI
    • (no location specified)
    Aug 9, 2022